合并症模式差异性地影响「难治性」类风湿关节炎患者的长期功能演变与疾病活动度
该前瞻性单中心队列研究纳入1264例类风湿关节炎患者,其中251例(19.9%)符合EULAR定义的难治性(D2T)类风湿关节炎。通过潜在类别轨迹分析,D2T患者的功能状态和疾病活动度长期演变均可分为四组;心理健康与疼痛相关疾病及代谢疾病合并症对mHAQ恶化和DAS28演变有显著贡献。
要点
- 1264例中251例(19.9%)符合EULAR定义的D2T类风湿关节炎。
- 首次b/ts-DMARD启用后6个月内DAS28-ESR未降低是成为D2T的显著预测因素。
- 心理健康与疼痛相关疾病及代谢疾病合并症与mHAQ恶化及DAS28演变显著相关。
核心结论
- D2T患者在长期病程上具有异质性,心理健康与疼痛相关疾病及代谢疾病合并症导致长期不良结局,应针对这些合并症以优化该类类风湿关节炎患者的预后。
研究设计与样本
- 前瞻性单中心队列研究,纳入1264例类风湿关节炎患者,应用EULAR的D2T定义,采用潜在类别轨迹分析评估功能状态(mHAQ)和疾病活动度(DAS28)的纵向聚类,并使用多重线性混合模型检验合并症及其聚类对长期结局的影响。
主要发现
- 1264例中251例(19.9%)被确定为D2T。
- younger age、纤维肌痛、骨关节炎、首次b/ts-DMARD启用时的DAS28-ESR以及b/ts-DMARD治疗前6个月内未能降低DAS28-ESR评分是患者成为D2T的显著预测因素。
- 长期随访(总计5872人年)显示功能状态演变分为四组:18.2%为稳定轻度受损mHAQ(均值0.41),39.9%为逐渐改善(1.21-0.87),另两组分别为缓慢恶化或稳定显著功能受损(HAQ>1)。
- 疾病活动度演变同样识别出四个不同组别。
- 在评估的不同合并症聚类中,存在「心理健康与疼痛相关疾病」或「代谢疾病」对mHAQ恶化均有显著贡献(两者p<0.0001),对DAS28演变亦有显著贡献(分别为p<0.0001和p=0.018)。
临床怎么用
- 作者认为,心理健康与疼痛相关疾病以及代谢疾病导致长期不良结局,应针对这些合并症以优化该类类风湿关节炎患者的预后。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Characterisation of the long-term outcome of patients with 'difficult to treat' (D2T) rheumatoid arthritis and factors contributing to its evolution are unknown. Herein, we explored the heterogeneity and contributing factors of D2T long-term outcome. METHODS: Patients included from a prospective single centre cohort study. The EULAR definition of D2T was applied. Longitudinal clustering of functional status (modified Health Assessment Questionnaire (mHAQ)) and disease activity (Disease Activity Score-28 (DAS28)) were assessed using latent-class trajectory analysis. Multiple linear mixed models were used to examine the impact of comorbidities and their clusters on the long-term outcome. RESULTS: 251 out of 1264 patients (19.9%) were identified as D2T. Younger age, fibromyalgia, osteoarthritis, DAS28-erythrocyte sedimentation rate (ESR) at first biological or targeted synthetic disease-modifying antirheumatic drug (b/ts-DMARD) initiation and failure to reduce DAS28-ESR scores within the first 6 months of b/ts-DMARD therapy were significant predictors of patients becoming D2T. Long-term follow-up (total of 5872 person-years) revealed four groups of functional status evolution: 18.2% had stable, mildly compromised mHAQ (mean 0.41), 39.9% had gradual improvement (1.21-0.87) and two groups had either slow deterioration or stable significant functional impairment (HAQ>1). Similarly, four distinct groups of disease activity evolution were identified. Among the different clusters of comorbidities assessed, presence of 'mental-health and pain-related illnesses' or 'metabolic diseases' had significant contribution to mHAQ worsening (p<0.0001 for both) and DAS28 evolution (p<0.0001 and p=0.018, respectively). CONCLUSION: D2T patients represent a heterogeneous group in terms of long-term disease course. Mental-health/pain-related illnesses as well as metabolic diseases contribute to long-term adverse outcomes and should be targeted in order to optimise the prognosis of this subset of rheumatoid arthritis.
引用
- Bertsias A, Flouri ID, Repa A, et al. Patterns of comorbidities differentially affect long-term functional evolution and disease activity in patients with 'difficult to treat' rheumatoid arthritis. RMD Open. 2024. PMID: 38242549. doi:10.1136/rmdopen-2023-003808
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。